$QDEL News

QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations

Why QuidelOrtho (QDEL) Stock Is Nosediving

QDEL Q2 Deep Dive: Guidance Reset Amid China Headwinds and Respiratory Uncertainty

QuidelOrtho Corporation 2026 Q2 - Results - Earnings Call Presentation

QuidelOrtho Corporation Q2 2026 Earnings Call Summary

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (NASDAQ:QDEL) Surprises With Q2 CY2026 Sales But Stock Drops 21.6%

QuidelOrtho Reports Second Quarter 2026 Financial Results

QuidelOrtho Lowers FY2026 Adj EPS Guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 Est; Lowers FY2026 Sales Guidance from $2.700B-$2.750B to $2.520B-$2.600B vs $2.705B Est

QuidelOrtho Q2 Adj. EPS $0.13 Beats $(0.05) Estimate, Sales $631.000M Beat $618.849M Estimate

Implied Volatility Surging for QuidelOrtho Stock Options

QuidelOrtho (QDEL) Stock Trades Cheap On Sales But Weak On Cash Flow

QuidelOrtho to Report Second Quarter 2026 Financial Results

3 Reasons to Sell QDEL and 1 Stock to Buy Instead

Beyond Fentanyl: How the Drug Crisis Is Changing

QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1